0001209191-19-020686.txt : 20190320 0001209191-19-020686.hdr.sgml : 20190320 20190320200017 ACCESSION NUMBER: 0001209191-19-020686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190319 FILED AS OF DATE: 20190320 DATE AS OF CHANGE: 20190320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahatme Sandesh CENTRAL INDEX KEY: 0001511034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 19695751 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-19 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001511034 Mahatme Sandesh 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP, CFO & CBO Common Stock 2019-03-19 4 M 0 11768 23.85 A 15636 D Common Stock 2019-03-19 4 M 0 3511 13.90 A 19147 D Common Stock 2019-03-19 4 M 0 164 13.71 A 19311 D Common Stock 2019-03-19 4 M 0 43 13.71 A 19354 D Common Stock 2019-03-19 4 F 0 2625 126.47 D 16729 D Common Stock 12012 I By trust Stock option (right to buy) 23.85 2019-03-19 4 M 0 11768 0.00 D 2013-11-05 2022-11-05 Common Stock 11768 0 D Stock option (right to buy) 13.90 2019-03-19 4 M 0 3511 0.00 D 2016-02-27 2025-02-27 Common Stock 3511 2625 D Stock option (right to buy) 13.71 2019-03-19 4 M 0 164 0.00 D 2017-02-28 2026-02-28 Common Stock 164 3370 D Stock option (right to buy) 13.71 2019-03-19 4 M 0 43 0.00 D 2017-02-28 2026-02-28 Common Stock 43 478 D Represents shares of common stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported on this Form 4 filing. Such an "option swap" enables the exercise and holding of shares of Common Stock by the reporting person. /s/ David Tyronne Howton, as Attorney-in-Fact for Sandesh Mahatme 2019-03-20